background
outbreak
becom
global
public
health
result
apart
clinic
featur
describ
previous
found
four
patient
decreas
immun
cell
refractori
hypoxemia
hospit
sever
hypoxemia
strongli
correl
express
level
immun
cell
addit
found
proport
probiot
significantli
reduc
bifidobacterium
lactobacillu
eubacterium
proport
condit
pathogen
bacteria
significantli
increas
corynebacterium
actinobacteria
ruthenibacterium
firmicut
notabl
patient
die
discuss
dynam
characterist
host
immun
system
imbal
gut
microbiota
critic
patient
hypoxemia
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
sever
close
relat
host
immun
cell
level
viciou
circl
immun
disord
gut
microbiota
imbal
may
high
risk
fatal
pneumonia
best
knowledg
first
studi
reveal
immunodeplet
refractori
hypoxemia
potenti
high
risk
subtyp
viciou
circl
immun
disord
gut
dysbiosi
may
high
risk
fatal
pneumonia
feb
case
confirm
china
countri
includ
south
korea
japan
itali
iran
global
public
health
emerg
attract
concern
throughout
world
host
immun
respons
essenti
clearanc
coronaviru
infect
balanc
coronaviru
host
immun
key
viral
pathogenesi
ultim
determin
infect
outcom
coronavirus
encod
numer
viral
gene
product
evad
suppress
host
immun
respons
sarsassoci
coronaviru
nonstructur
protein
abl
inhibit
host
interferondepend
antivir
signal
well
anoth
sar
coronaviru
protein
name
open
read
suppress
mitochondria
immun
cell
coronaviru
suppress
host
immun
demonstr
howev
alter
immun
system
patient
yet
well
understood
studi
aim
describ
dynam
characterist
immun
system
critic
patient
refractori
hypoxemia
discuss
relationship
hypoxemia
sever
immun
cell
level
hope
reveal
immunodeplet
carri
higher
risk
death
patient
retrospect
studi
patient
infect
admit
renmin
hospit
wuhan
univers
wuhan
china
januari
februari
patient
diagnos
classifi
base
diagnosi
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
method
procedur
conduct
describ
supplement
appendix
categor
variabl
express
percentag
continu
variabl
directli
express
rang
compar
differ
gut
microbiota
patient
health
cohort
data
import
arumugam
research
compar
analysi
conduct
two
tail
test
data
analys
perform
use
spss
softwar
p
valu
consid
signific
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
three
male
adult
patient
diagnos
pneumonia
admit
renmin
hospit
wuhan
univers
januari
februari
patient
patient
patient
respect
mean
age
patient
year
patient
medic
histori
prostat
hyperplasia
patient
chronic
bronchiti
patient
report
underli
histor
medic
condit
collect
clinic
featur
found
patient
report
fever
dyspnea
tabl
moreov
patient
also
diarrhea
patient
cough
myalgiafatigu
addit
laboratori
find
show
creactiv
protein
crp
obvious
increas
patient
decreas
lymphocyt
count
increas
procalcitonin
observ
patient
tabl
addit
patient
also
elev
hypersensit
troponin
creatin
urea
serum
indic
myocardi
injuri
renal
function
damag
patient
increas
aspart
aminotransferas
asl
alanin
aminotransferas
alt
tabl
indic
liver
injuri
hospit
patient
receiv
empir
antivir
antibiot
treatment
tabl
patient
also
experienc
intraven
immunoglobulin
therapi
day
hospit
tabl
notabl
three
patient
die
day
hospit
respect
determin
dynam
chang
differ
immun
cell
patient
analyz
nk
cell
peripher
blood
three
patient
differ
time
point
hospit
shown
figur
patient
sustain
decreas
type
immun
cell
cours
specif
cell
count
alway
normal
rang
b
cell
count
drop
normal
rang
day
nk
cell
count
drop
normal
rang
day
simultan
patient
receiv
oxygen
support
oxygen
mask
lmin
even
high
flow
oxygen
figur
due
hypoxemia
howev
oximetri
satur
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
still
recov
day
invas
mechan
ventil
use
due
sudden
respiratori
failur
nt
work
patient
die
day
patient
sustain
decreas
type
immun
cell
first
six
day
normal
rang
figur
hypoxemia
oxygen
mask
high
flow
oxygen
use
correct
hypoxemia
almost
decreas
along
way
day
figur
eventu
patient
die
day
patient
cell
obvious
decreas
normal
rang
cell
present
sustain
declin
day
figur
addit
oxygen
support
oxygen
mask
lmin
patient
oddli
declin
day
noninvas
mechan
ventil
use
nt
work
figur
patient
present
progress
refractori
hypoxemia
die
day
result
found
patient
immunodeplet
refractori
hypoxemia
interestingli
phenomenon
immunodeplet
appear
earlier
refractori
hypoxemia
patient
progress
pneumonia
nt
test
analyz
gut
microbiota
level
phylum
genu
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
increas
ruthenibacterium
genu
level
significantli
higher
health
cohort
p
time
aspergillu
domin
intestin
fungal
flora
patient
overal
data
significantli
differ
healthi
human
gut
microbiota
p
studi
reveal
clinic
characterist
critic
patient
found
hypoxemia
sever
strongli
correl
express
level
immun
cell
indic
immunodeplet
may
well
key
risk
factor
develop
imbal
gut
microbiota
also
found
critic
patient
may
lead
microbi
transloc
second
infect
balanc
viru
host
immun
close
associ
outcom
infect
clinic
studi
shown
coronaviru
infect
sever
link
patient
health
statu
immunocompromis
state
carri
increas
risk
death
also
demonstr
immunosuppress
rhesu
macaqu
markedli
increas
merscoronaviru
replic
lung
suggest
inabl
viru
clearanc
multipl
studi
demonstr
interact
immun
system
gut
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
microbiota
gut
microbiota
homeostasi
modul
immun
system
shown
varieti
immun
factor
capabl
alter
gut
microbiota
homeostasi
balanc
nodlik
receptor
protein
iga
imbal
dysbiosi
gut
microbiota
would
contribut
enhanc
mucos
permeabl
thu
lead
microbi
transloc
second
infect
moreov
gut
microbiota
abl
modul
immun
respons
play
import
role
immunemedi
diseas
suggest
viciou
circl
immun
disord
gut
microbiota
imbal
find
indic
balanc
gut
microbiota
disrupt
case
coronaviru
infect
due
immun
disord
studi
identifi
chang
gut
microbiota
novel
coronaviru
infect
found
proport
probiot
significantli
reduc
bifidobacterium
lactobacillu
eubacterium
proport
condit
pathogen
bacteria
significantli
increas
corynebacterium
actinobacteria
ruthenibacterium
firmicut
addit
also
found
fungi
gut
microbiota
two
patient
common
fungi
healthi
cohort
eg
candida
saccharomyc
cerevisia
rare
fungi
domin
fungal
gut
microbiota
aspergillu
kluyveromyc
insight
speci
microbiota
alter
immunedeplet
associ
novel
coronaviru
infect
help
us
better
understand
characterist
base
find
suggest
earli
intervent
host
immun
system
gut
microbiota
necessari
patient
refractori
hypoxia
critic
patient
extracorpor
membran
oxygen
ecmo
therapi
also
support
earli
amelior
symptom
refractori
hypoxia
conclus
discuss
dynam
characterist
host
immun
system
imbal
gut
microbiota
critic
patient
hypoxemia
sever
close
relat
host
immun
cell
level
viciou
circl
immun
disord
gut
microbiota
imbal
may
high
risk
fatal
pneumonia
